Kevin Feeley, CHIEF FINANCIAL OFFICER at GeneDx Holdings Corp. (WGS), sold 11,996 shares at $107.68 ($1.3M) on 2025-09-30, disclosed to the SEC on 2025-10-01.
Scheduled sale ($1.3M) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.24 | 344 | $36K | 2.8% |
| 2 | $106.86 | 387 | $41K | 3.2% |
| 3 | $107.68 | 2,715 | $292K | 22.5% |
| 4 | $107.68 | 2,715 | $292K | 22.5% |
| 5 | $108.67 | 2,152 | $234K | 18.0% |
| 6 | $108.67 | 2,152 |
| $234K |
| 18.0% |
| 7 | $110.05 | 421 | $46K | 3.6% |
| 8 | $111.93 | 520 | $58K | 4.5% |
| 9 | $111.93 | 520 | $58K | 4.5% |
| 10 | $113.68 | 70 | $8K | 0.6% |
| Total | $108.43 avg | 11,996 | $1.3M | 100% |
| Filing → |
| WGS | SELL | 2026-09-03 | $31K | — | Filing → |
| WGS | SELL | 2026-06-18 | $227K | — | Filing → |
| WGS | SELL | 2026-06-11 | $68K | — | Filing → |